Want to join the conversation?
Manchester, UK-based company $PNR said that 2015-end free cash flow was $643MM, which was short of the company's $700MM forecast. This has been impacted by working capital timing due to the top line softness $PNR experienced. The company expects 2016 free cash flow to return to greater than 100% of adjusted net income.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.